Biomanufacturing Industry News
-
Siemens Corporate Research Develops RAPID2 System For Fast Discovery Of Discriminative Pathogen Signatures
5/25/2009
Siemens Corporate Research (SCR), Inc. (www.usa.siemens.com/en/research) announced that it developed the RAPID2 system to speed the biomarker discovery process for the development of rapid diagnostic tests.
-
Biomedical Sciences Companies Expanding In Asia Invested More Than US$500M In Singapore
5/19/2009
Global biomedical sciences companies invested more than US$500 million in Singapore in the year 2008.
-
Novavax Announces Enrollment In The Second Phase II Study Of Its Seasonal Influenza VLP Vaccine Candidate
5/7/2009
Novavax, Inc. (Nasdaq: NVAX) announced today vaccination of healthy volunteers in the second clinical trial of its virus-like particle (VLP) seasonal influenza vaccine.
-
NeoStem Obtains Exclusive Worldwide License For Innovative Stem Cell Technology And Applications To Heal Chronic Wounds
5/5/2009
NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed an agreement to license the exclusive worldwide rights to an innovative product and procedure using autologous bone marrow-derived stem cells to promote the healing of chronic wounds.
-
Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer As First True Automation-Friendly Osmometer For The Biopharmaceutical Industry
4/22/2009
Advanced Instruments, Inc. today introduced the Advanced(R) 2020-BIO Multi-Sample Osmometer as the first true automation-friendly osmometer for the biopharmaceutical industry.
-
INFORM-1 Clinical Trial Amended To Further Explore Promising Direct Antiviral Regimen In HCV Patients
4/22/2009
InterMune, Inc. (Nasdaq: ITMN) today announced that the innovative clinical study of protease inhibitor ITMN-191 (R7227) in combination with nucleoside polymerase inhibitor R7128 (Roche/Pharmasset), referred to as the INFORM-1 study, has been successfully amended to include additional cohorts to explore the combination in treatment-experienced and null responder HCV patients.
-
Millipore And Applikon Biotechnology Form Collaboration To Expand Offerings In Fast-Growing Disposable Manufacturing Market
11/4/2008
Millipore Corporation and Applikon Biotechnology B.V. today announced an agreement to co-develop and distribute disposable bioreactor systems for biopharmaceutical applications.
-
Applied Biosystems Stockholders Approve Merger With Invitrogen
10/28/2008
Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company’s proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today.
-
California Healthcare Institute To Host Forum On Molecular Diagnostics Regulation And Reimbursement Keeping Pace With Technology
9/16/2008
California Healthcare Institute (CHI) and national experts in the molecular and in vitro diagnostics (IVD) industry. Keeping Pace with Technology: Molecular Diagnostics Regulation and Reimbursement.
-
Geron Announces Issuance Of U.S. Patent For Cardiomyocytes From Human Embryonic Stem Cells
9/16/2008
Geron Corporation today announced the issuance of U.S. Patent No. 7,425,448, with broad claims to cardiomyocytes derived from human embryonic stem cells (hESCs).
This website uses cookies to ensure you get the best experience on our website. Learn more